Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 1, open label, single center, single dose, two-way crossover comparative bioavailability/bioequivalent study comparing Aspargo's Sildenafil Oral Spray, an oral liquid suspension formulation of sildenafil citrate, with VIAGRA® tablets in healthy male subjects.

Next Previous
X
Search
Trial Profile

A phase 1, open label, single center, single dose, two-way crossover comparative bioavailability/bioequivalent study comparing Aspargo's Sildenafil Oral Spray, an oral liquid suspension formulation of sildenafil citrate, with VIAGRA® tablets in healthy male subjects.

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 31 Jul 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sildenafil (Primary) ; Sildenafil
  • Indications Erectile dysfunction
  • Focus Pharmacokinetics
  • Sponsors Aspargo Laboratories

    • Most Recent Events

    • 30 Jul 2024 According to an Aspargo Laboratories media release, company seek to collaborate with the FDA to file an NDA for ASP-001 for the treatment of Erectile-dysfunction under the 505(b)2 regulatory pathway.
    • 30 Jul 2024 According to an Aspargo Laboratories media release, the study results were published in the International Journal of Science and Research (IJSR).
    • 30 Jul 2024 Results published in the Aspargo Laboratories media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top